Lynx Investment Advisory Integra Lifesciences Holdings Corp Transaction History
Lynx Investment Advisory
- $135 Billion
- Q2 2024
A detailed history of Lynx Investment Advisory transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Lynx Investment Advisory holds 27 shares of IART stock, worth $463. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27Holding current value
$463% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IART
# of Institutions
255Shares Held
75.5MCall Options Held
10.7KPut Options Held
57.7K-
Black Rock Inc. New York, NY11.3MShares$193 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.77MShares$134 Million0.0% of portfolio
-
Morgan Stanley New York, NY5.5MShares$94.5 Million0.01% of portfolio
-
Eaton Vance Management Boston, MA4.22MShares$72.4 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA3.89MShares$66.8 Million0.02% of portfolio
About INTEGRA LIFESCIENCES HOLDINGS CORP
- Ticker IART
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 83,518,200
- Market Cap $1.43B
- Description
- Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...